Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study

| October 9, 2016 | 0 Comments

loudon_sep_oct_2016_artby Franco Di Cesare, MD; Jessica Mancuso, PhD; Brian Silver, MD; and Peter T. Loudon, PhD
Dr. Di Cesare is with Leoben Research Limited in Glasgow, UK; Dr. Mancuso is with Research Statistics at Pfizer in Groton, Connecticut, USA; Dr. Silver is with Rhode Island Hospital and Alpert Medical School of Brown University in Providence, Rhode Island, USA; and Dr. Loudon is with the Neuroscience and Pain Research Unit at Pfizer in Cambridge, UK.

Innov Clin Neurosci. 2016;13(9–10):32–43

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , ,

Category: Assessment Tools, Cerebrovascular Disease, Cognition, Dementia, Neurologic Systems and Symptoms, Neurology, Original Research, Past Articles, Stroke, Trial Methodology

Leave a Reply